Household Healthcare Sector

Orthocell

Market Cap: AU$296.4m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

CARGO Therapeutics

Market Cap: US$190.4m

A clinical-stage biotechnology company, develops chimeric antigen receptor (CAR) T-cell therapies for cancer patients.

scPharmaceuticals

Market Cap: US$189.0m

A pharmaceutical company, focuses on developing and commercializing products to optimize the delivery of infused therapies and patient care.

Eledon Pharmaceuticals

Market Cap: US$188.6m

Operates as a clinical stage biotechnology company.

Kodiak Sciences

Market Cap: US$188.4m

A clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases.

Pacific Smiles Group

Market Cap: AU$291.7m

Owns and operates dental centers under the Pacific Smiles Dental Centres and Nib Dental Care Centres names in Australia.

Inhibrx Biosciences

Market Cap: US$186.9m

A clinical-stage biopharmaceutical company, engages in the development of biologic therapeutics for people with life-threatening conditions.

Kindly MD

Market Cap: US$186.7m

A healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services.

Sight Sciences

Market Cap: US$186.6m

An ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases.

Omeros

Market Cap: US$185.7m

A clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases.

Avacta Group

Market Cap: UK£136.5m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

High Tide

Market Cap: CA$254.1m

Engages in the cannabis retail business in Canada, the United States, and internationally.

Panamera Holdings

Market Cap: US$182.0m

Does not have significant operations.

Journey Medical

Market Cap: US$181.8m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Organigram Global

Market Cap: CA$250.4m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

UroGen Pharma

Market Cap: US$181.2m

Engages in the development and commercialization of solutions for urothelial and specialty cancers.

Deltex Medical Group

Market Cap: US$180.6m

Manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, and internationally.

Stereotaxis

Market Cap: US$180.6m

Designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.

TriSalus Life Sciences

Market Cap: US$180.4m

Engages in the research, development, and commercialization of drug delivery technology platform and immuno-oncology therapeutics to improve outcomes for patients with difficult-to-treat liver and pancreatic cancers.

ProQR Therapeutics

Market Cap: US$179.1m

A biotechnology company, focuses on the discovery and development of novel therapeutic medicines.

DiaMedica Therapeutics

Market Cap: US$178.4m

A clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from severe ischemic diseases.

Spectral Medical

Market Cap: CA$245.2m

Focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally.

CVRx

Market Cap: US$176.0m

A commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally.

AFT Pharmaceuticals

Market Cap: NZ$294.7m

Engages in the development, marketing, and distribution of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

Inogen

Market Cap: US$175.6m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

Utah Medical Products

Market Cap: US$175.6m

Provides medical devices for the healthcare industry worldwide.

Instil Bio

Market Cap: US$175.5m

A clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies.

INmune Bio

Market Cap: US$170.8m

A clinical-stage immunology company, focuses on developing drugs to reprogram the patients innate immune system to treat disease in the United States.

Electromed

Market Cap: US$170.5m

Develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally.

Cybin

Market Cap: US$170.4m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

Puma Biotechnology

Market Cap: US$167.3m

A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.

AC Immune

Market Cap: US$167.2m

A clinical stage biopharmaceutical company, discovers, designs, and develops medicines, and therapeutic and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding.

Lucid Diagnostics

Market Cap: US$164.4m

Operates as a commercial-stage medical diagnostics technology company in the United States.

AVITA Medical

Market Cap: US$164.2m

Operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom.

Accuray

Market Cap: US$163.8m

Designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Asia, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.